Literature DB >> 12840029

Elucidation of primary structure elements controlling early amyloid beta-protein oligomerization.

Gal Bitan1, Sabrina S Vollers, David B Teplow.   

Abstract

Assembly of monomeric amyloid beta-protein (A beta) into oligomeric structures is an important pathogenetic feature of Alzheimer's disease. The oligomer size distributions of aggregate-free, low molecular weight A beta 40 and A beta 42 can be assessed quantitatively using the technique of photo-induced cross-linking of unmodified proteins. This approach revealed that low molecular weight A beta 40 is a mixture of monomer, dimer, trimer, and tetramer, in rapid equilibrium, whereas low molecular weight A beta 42 preferentially exists as pentamer/hexamer units (paranuclei), which self-associate to form larger oligomers. Here, photo-induced cross-linking of unmodified proteins was used to evaluate systematically the oligomerization of 34 physiologically relevant A beta alloforms, including those containing familial Alzheimer's disease-linked amino acid substitutions, naturally occurring N-terminal truncations, and modifications altering the charge, the hydrophobicity, or the conformation of the peptide. The most important structural feature controlling early oligomerization was the length of the C terminus. Specifically, the side-chain of residue 41 in A beta 42 was important both for effective formation of paranuclei and for self-association of paranuclei into larger oligomers. The side-chain of residue 42, and the C-terminal carboxyl group, affected paranucleus self-association. A beta 40 oligomerization was particularly sensitive to substitutions of Glu22 or Asp23 and to truncation of the N terminus, but not to substitutions of Phe19 or Ala21. A beta 42 oligomerization, in contrast, was largely unaffected by substitutions at positions 22 or 23 or by N-terminal truncations, but was affected significantly by substitutions of Phe19 or Ala21. These results reveal how specific regions and residues control A beta oligomerization and show that these controlling elements differ between A beta 40 and A beta 42.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12840029     DOI: 10.1074/jbc.M300825200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  100 in total

1.  Atomic view of a toxic amyloid small oligomer.

Authors:  Arthur Laganowsky; Cong Liu; Michael R Sawaya; Julian P Whitelegge; Jiyong Park; Minglei Zhao; Anna Pensalfini; Angela B Soriaga; Meytal Landau; Poh K Teng; Duilio Cascio; Charles Glabe; David Eisenberg
Journal:  Science       Date:  2012-03-09       Impact factor: 47.728

2.  Molecular dynamics simulation of amyloid beta dimer formation.

Authors:  B Urbanc; L Cruz; F Ding; D Sammond; S Khare; S V Buldyrev; H E Stanley; N V Dokholyan
Journal:  Biophys J       Date:  2004-10       Impact factor: 4.033

3.  Mapping conformational ensembles of aβ oligomers in molecular dynamics simulations.

Authors:  Seongwon Kim; Takako Takeda; Dmitri K Klimov
Journal:  Biophys J       Date:  2010-09-22       Impact factor: 4.033

4.  Globular state in the oligomers formed by Abeta peptides.

Authors:  Seongwon Kim; Takako Takeda; Dmitri K Klimov
Journal:  J Chem Phys       Date:  2010-06-14       Impact factor: 3.488

5.  Despite its role in assembly, methionine 35 is not necessary for amyloid beta-protein toxicity.

Authors:  Panchanan Maiti; Aleksey Lomakin; George B Benedek; Gal Bitan
Journal:  J Neurochem       Date:  2010-03-20       Impact factor: 5.372

6.  Perturbed amelogenin secondary structure leads to uncontrolled aggregation in amelogenesis imperfecta mutant proteins.

Authors:  Rajamani Lakshminarayanan; Keith M Bromley; Ya-Ping Lei; Malcolm L Snead; Janet Moradian-Oldak
Journal:  J Biol Chem       Date:  2010-10-07       Impact factor: 5.157

7.  A two-step strategy for structure-activity relationship studies of N-methylated aβ42 C-terminal fragments as aβ42 toxicity inhibitors.

Authors:  Huiyuan Li; Reeve Zemel; Dahabada H J Lopes; Bernhard H Monien; Gal Bitan
Journal:  ChemMedChem       Date:  2012-02-03       Impact factor: 3.466

8.  In silico study of amyloid beta-protein folding and oligomerization.

Authors:  B Urbanc; L Cruz; S Yun; S V Buldyrev; G Bitan; D B Teplow; H E Stanley
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-06       Impact factor: 11.205

9.  Solvent and mutation effects on the nucleation of amyloid beta-protein folding.

Authors:  Luis Cruz; Brigita Urbanc; Jose M Borreguero; Noel D Lazo; David B Teplow; H Eugene Stanley
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-09       Impact factor: 11.205

10.  Heparin nanoparticles for β amyloid binding and mitigation of β amyloid associated cytotoxicity.

Authors:  Peng Wang; Hovig Kouyoumdjian; David C Zhu; Xuefei Huang
Journal:  Carbohydr Res       Date:  2014-08-02       Impact factor: 2.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.